6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2(3H)-one

Catalog No. :
ACXJUZ257
CAS No. :
1613639-44-3
Molecular Formula :
C13H16BNO3S
Molecular Weight :
277.15

IUPAC Name:6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2(3H)-one

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2(3H)-one
IUPAC Name6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2(3H)-one
Molecular FormulaC13H16BNO3S
Molecular Weight277.15
SMILESO=C1SC2=CC(B3OC(C)(C)C(C)(C)O3)=CC=C2N1
InChI KeyOIRXQAILTDQHNR-UHFFFAOYSA-N
Synonym2(3H)-Benzothiazolone, 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazol-2(3H)-one;2-Benzothiazolinone-6-boronic acid pinacol ester
CAS No.1613639-44-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACXJUZ257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACYQLJ419 route compound structure diagram
    ACYQLJ41962266-82-4 In Stock
  4. Then
  5. ACXJUZ257 route product structure diagram
    ACXJUZ2571613639-44-3
Inquiry

2. ACXJUZ257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXJUZ257 route product structure diagram
    ACXJUZ2571613639-44-3
Inquiry

Comments (0)